Literature DB >> 19141168

Hereditary haemorrhagic telangiectasia.

A A Sharathkumar1, A Shapiro.   

Abstract

Hereditary haemorrhagic telangiectasia (also known as Osler-Weber-Rendu syndrome) is a relatively common, under-recognized autosomal-dominant disorder that results from multisystem vascular dysplasia. It is characterized by telangiectases and arteriovenous malformations of skin, mucosa and viscera. This article summarizes the clinical manifestations and the management of this disorder and its management. This review underscores an urgent need to conduct prospective multicentre studies to develop evidence-based management guidelines for this disease.

Entities:  

Mesh:

Year:  2008        PMID: 19141168     DOI: 10.1111/j.1365-2516.2008.01774.x

Source DB:  PubMed          Journal:  Haemophilia        ISSN: 1351-8216            Impact factor:   4.287


  18 in total

Review 1.  Bleeding and clotting in hereditary hemorrhagic telangiectasia.

Authors:  Christopher Dittus; Michael Streiff; Jack Ansell
Journal:  World J Clin Cases       Date:  2015-04-16       Impact factor: 1.337

2.  Osler-Weber-Rendu syndrome: a rare cause of iron deficiency.

Authors:  Abdullah Ozkok; Timur Selcuk Akpinar; Vakur Akkaya
Journal:  J Gen Intern Med       Date:  2011-03-05       Impact factor: 5.128

3.  Spectral imaging reveals microvessel physiology and function from anastomoses to thromboses.

Authors:  Mamta Wankhede; Nikita Agarwal; Rodrigo A Fraga-Silva; Casey deDeugd; Mohan K Raizada; S Paul Oh; Brian S Sorg
Journal:  J Biomed Opt       Date:  2010 Jan-Feb       Impact factor: 3.170

4.  Epistaxis: a common problem.

Authors:  Adil Fatakia; Ryan Winters; Ronald G Amedee
Journal:  Ochsner J       Date:  2010

Review 5.  Novel treatments for epistaxis in hereditary hemorrhagic telangiectasia: a systematic review of the clinical experience with thalidomide.

Authors:  Massimo Franchini; Francesco Frattini; Silvia Crestani; Carlo Bonfanti
Journal:  J Thromb Thrombolysis       Date:  2013-10       Impact factor: 2.300

Review 6.  Differential diagnosis of hepatopulmonary syndrome (HPS): Portopulmonary hypertension (PPH) and hereditary hemorrhagic telangiectasia (HHT).

Authors:  Inna Krynytska; Mariya Marushchak; Anna Mikolenko; Anzhela Bob; Iryna Smachylo; Ludmyla Radetska; Olga Sopel
Journal:  Bosn J Basic Med Sci       Date:  2017-11-20       Impact factor: 3.363

7.  The Stratified Population Screening of Hereditary Hemorrhagic Telangiectasia.

Authors:  Tamás Major; Réka Gindele; Zsuzsanna Szabó; Zsuzsanna Kis; László Bora; Natália Jóni; Péter Bárdossy; Tamás Rácz; Zsuzsanna Bereczky
Journal:  Pathol Oncol Res       Date:  2019-01-26       Impact factor: 3.201

Review 8.  Standard anticoagulation for mesenteric vein thrombosis, revealing a 'zebra' diagnosis: hereditary haemorrhagic telangiectasia--the dripping truth!

Authors:  Aakash Aggarwal; Arundeep Singh Kahlon; Meghan Rane; Emerald Banas
Journal:  BMJ Case Rep       Date:  2013-10-28

9.  Individualized therapy of HHT driven by network analysis of metabolomic profiles.

Authors:  Neema Jamshidi; Franklin J Miller; Jess Mandel; Timothy Evans; Michael D Kuo
Journal:  BMC Syst Biol       Date:  2011-12-20

10.  Redo cardiac surgery for active prosthetic valve endocarditis associated with hereditary hemorrhagic telangiectasia: report of a case.

Authors:  Yuki Nakamura; Fumiaki Shikata; Masahiro Ryugo; Toru Okamura; Takumi Yasugi; Hironori Izutani
Journal:  Surg Today       Date:  2014-03-20       Impact factor: 2.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.